Sasa S, Inoue H, Nakagawa M, Toba H, et al. Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer. Clin Breast Cancer 2024 Feb 22:S1526-8209(24)00052.
PMID: 38462397